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Introduction {#sec1}
============

MicroRNAs (miRNAs) are short, endogenous, non-coding RNAs that repress gene expression post-transcriptionally by destabilizing and/or repressing translation of target mRNAs. In the canonical biogenesis pathway, primary microRNA transcripts (pri-miRNAs) are processed in the nucleus by the microprocessor complex, which consists of the RNase III enzyme DROSHA and the double-stranded RNA-binding protein DGCR8, to generate ∼70-nt precursor miRNAs (pre-miRNAs). The pre-miRNAs are then exported to the cytoplasm by EXPORTIN-5 and further processed by another RNase III enzyme, DICER, to generate ∼22-nt mature miRNAs ([Figure S1](#mmc1){ref-type="supplementary-material"}) ([@bib16]). More than 400 miRNAs have been identified in the human ([@bib18]), and up to 60% of all human genes may be regulated by miRNAs ([@bib7]).

Given the potentially vast regulatory influence of miRNAs on gene expression and the critical roles of these molecules in embryo development ([@bib4], [@bib34]), it is not surprising that miRNAs have emerged as important regulators in reprogramming somatic cells into induced pluripotent stem cells (iPSCs). Together with the Yamanaka factors (OCT4, SOX2, KLF4, and c-MYC) ([@bib35]), co-expression of the miRNA cluster 302/367 or 106a/363; members of the miR-302, miR-294, or miR-181 family; or miR-93 and miR-106b greatly enhance iPSC derivation efficiency ([@bib10], [@bib21], [@bib22], [@bib23], [@bib32]). Furthermore, expression of the miR-302/367 cluster or miR-200c, miR-302, and miR-369 without the Yamanaka factors is sufficient to reprogram human and mouse fibroblasts ([@bib2], [@bib26]). How these miRNAs promote reprogramming is only partially understood. Several mechanisms have been proposed, such as acceleration of mesenchymal to epithelial transition and antagonism of the activities of let-7 family miRNAs, MBD2, NR2F2, and/or other reprogramming suppressors ([@bib9], [@bib10], [@bib20], [@bib22], [@bib25]).

In addition to the miRNAs that promote reprogramming, several miRNAs that inhibit reprogramming, such as the let-7 family members, have been reported ([@bib25], [@bib36]). Therefore, it remains unclear whether miRNA activity as a whole facilitates reprogramming and whether miRNAs are required to convert somatic cells into iPSCs. Previous attempts to reprogram *Dicer* null mouse embryonic fibroblasts (MEFs) were unsuccessful ([@bib13]); however, this observation cannot rule out a requirement of miRNAs in reprogramming because DICER is also critical for the biogenesis of several other small RNAs, such as endogenous small hairpin RNAs (shRNAs), mirtrons, and endogenous small interfering RNAs (siRNAs) ([Figure S1](#mmc1){ref-type="supplementary-material"}) ([@bib3]). In this study, we addressed the question of whether miRNAs are required for generating iPSC by reprogramming mouse cells that lack *Dgcr8*, a factor required specifically for the biogenesis of canonical miRNAs ([Figure S1](#mmc1){ref-type="supplementary-material"}), including all miRNAs implicated in reprogramming ([@bib3], [@bib10], [@bib37]). We report that *Dgcr8*-deficient fibroblasts and NSCs can be reprogrammed by the Yamanaka factors, albeit at decreased efficiencies. These results demonstrate that while canonical miRNAs as a whole facilitate reprogramming, they may be dispensable for the derivation of iPSCs.

Results {#sec2}
=======

Reprogramming of *Dgcr8*^Δ/Δ^ MEFs and Tail Tip Fibroblasts {#sec2.1}
-----------------------------------------------------------

To assess the requirement of miRNAs in iPSC derivation, we first tested whether *Dgcr8*-deficient MEFs and tail tip fibroblasts (TTFs) could be reprogrammed by Yamanaka factors. Because *Dgcr8* null embryos become grossly malformed by embryonic day (E) 6.5 and absorbed by E10 ([@bib37]), isolation of MEFs or TTFs from *Dgcr8* null mice was not possible. Instead, we obtained *Dgcr8*^Δ/Δ^ fibroblasts by Cre-mediated disruption of *Dgcr8* in *Dgcr8*^flox/flox^ MEFs or TTFs ([Figure 1](#fig1){ref-type="fig"}A) ([@bib33], [@bib37]). To monitor Cre activity and enable purification of *Dgcr8*^Δ/Δ^ fibroblasts, we isolated MEFs or TTFs from *Dgcr8*^flox/flox^ mice carrying a ROSA26-LoxP-STOP-LoxP-YFP (R26-LSL-YFP) reporter ([@bib31]). A previous report demonstrated that mature miRNAs are eliminated in *Dicer*^Δ/Δ^ MEFs by 6 days after transduction of Cre-expressing lentivirus ([@bib13]). To measure the levels of mature miRNAs after *Dgcr8* disruption, we performed qPCR analyses on *Dgcr8*^flox/flox^ and *Dgcr8*^Δ/Δ^ TTFs 7 and 10 days after Cre expression. Among the miRNAs examined, we found that let-7b, miR-20a, and miR-181a were reliably expressed in the *Dgcr8*^flox/flox^ TTFs, but expression of all three miRNAs was reduced to negligible levels in the *Dgcr8*^Δ/Δ^ TTFs ([Figure 1](#fig1){ref-type="fig"}B), which is consistent with the previous report ([@bib13]). To ensure that only *Dgcr8*^Δ/Δ^ fibroblasts were used for reprogramming and to exclude those cells that may disrupt *Dgcr8* during reprogramming, we sorted YFP+ cells 48 hr after transduction of the Cre adenovirus ([Figures 1](#fig1){ref-type="fig"}A and 1C). The sorted YFP+ cells were then cultured to 7 or 10 days after Cre adenovirus transduction to deplete miRNAs ([Figure 1](#fig1){ref-type="fig"}A). The resulting cells were transduced with STEMCCA lentivirus, which expresses all four Yamanaka factors in a single polycistronic transcript ([@bib30]), to generate iPSCs ([Figure 1](#fig1){ref-type="fig"}A). Both *Dgcr8*^Δ/Δ^ MEFs and TTFs yielded iPSC colonies in 3 weeks ([Figure 1](#fig1){ref-type="fig"}D) at reprogramming efficiencies of 0.002%--0.02%, which was significantly lower than the 0.4%--0.6% efficiency of control *Dgcr8*^flox/flox^ fibroblasts ([Figure 1](#fig1){ref-type="fig"}E). Genotyping confirmed that the majority of the resulting iPSCs had both *Dgcr8* alleles disrupted; however, approximately 15% of YFP+ iPSCs retained one functional allele of *Dgcr8*, suggesting that the R26-LSL-YFP reporter is imperfect in monitoring disruption of endogenous genes and that those fibroblasts expressing a single *Dgcr8* allele would have a reprogramming advantage ([Figure 1](#fig1){ref-type="fig"}F; [Table S1](#mmc1){ref-type="supplementary-material"}).

Reprogramming of *Dgcr8*^Δ/Δ^ Mouse Neural Stem Cells {#sec2.2}
-----------------------------------------------------

Though the miRNAs in *Dgcr8*^Δ/Δ^ fibroblasts were under the qPCR detection limit ([Figure 1](#fig1){ref-type="fig"}B), we could not exclude the possibility that a residual amount of miRNAs remains in a small percentage of fibroblasts 7--10 days after Cre transduction and is required for reprogramming. *Dgcr8*^Δ/Δ^ fibroblasts quickly deteriorate in culture (data not shown), which precludes long-term passaging to eliminate any residual miRNAs through cell division-mediated dilution and miRNA degradation. In contrast, neural stem cells (NSCs) can be cultured long term in vitro ([@bib1], [@bib12]), so we used *Dgcr8*^flox/flox^ NSCs to further examine the requirement of miRNAs in reprogramming ([Figure 2](#fig2){ref-type="fig"}A). We isolated NSCs from brains of E13.5 *Dgcr8*^flox/flox^; *R26-LSL-YFP* mice and disrupted *Dgcr8* by transduction of Cre adenovirus ([Figure 2](#fig2){ref-type="fig"}A). YFP+ NSCs underwent fluorescence-activated cell sorting (FACS) 48 hr after Cre transduction to exclude cells that had not yet activated Cre. We continuously cultured the sorted *Dgcr8*^Δ/Δ^ NSCs for 45--60 days (9--12 passages) ([Figure 2](#fig2){ref-type="fig"}B) to ensure exhaustion of any residual miRNAs by cell division-mediated dilution and degradation. PCR-based genotyping analysis detected no contamination of cells with incomplete *Dgcr8* disruption in the prolonged culture of *Dgcr8*^Δ/Δ^ NSCs ([Figure 2](#fig2){ref-type="fig"}C). The qPCR analysis confirmed that *Dgcr8*^Δ/Δ^ NSCs did not express mature miRNAs such as miR-20a, miR-181a, let-7b, and miR-9/9^∗^, which are abundantly expressed in *Dgcr8*^flox/flox^ NSCs ([Figure 2](#fig2){ref-type="fig"}D). The resulting *Dgcr8*^Δ/Δ^ NSCs were then transduced with STEMCCA lentivirus to generate iPSCs. The control *Dgcr8*^flox/flox^ NSCs were reprogrammed at an efficiency of 0.5%, which is comparable to published data ([@bib14]). We detected YFP+ iPSC colonies 4 weeks after STEMCCA transduction of *Dgcr8*^Δ/Δ^ NSCs at efficiencies of 0.01%--0.05% ([Figures 2](#fig2){ref-type="fig"}E and 2F). Genotyping of the resulting iPSCs confirmed that *Dgcr8* was disrupted in all examined clones ([Figure 2](#fig2){ref-type="fig"}C; [Figure S2](#mmc1){ref-type="supplementary-material"}).

Characterization of *Dgcr8*^Δ/Δ^ iPSCs {#sec2.3}
--------------------------------------

The *Dgcr8*^Δ/Δ^ iPSCs derived from fibroblasts or NSCs expressed pluripotency-associated markers such as alkaline phosphatase (AP), SSEA-1, and NANOG ([Figures 3](#fig3){ref-type="fig"}A--3C′; [Figure S3](#mmc1){ref-type="supplementary-material"}A). The qPCR analysis confirmed the lack of *Dgcr8* expression in *Dgcr8*^Δ/Δ^ iPSCs ([Figure 3](#fig3){ref-type="fig"}D). Karyotyping analyses demonstrated that normal *Dgcr8*^Δ/Δ^ iPSCs could be isolated ([Figure 3](#fig3){ref-type="fig"}E; [Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C). The qPCR analyses revealed that Yamanaka factors delivered by the STEMCCA lentivirus were largely silenced in *Dgcr8*^Δ/Δ^ iPSCs ([Figure 3](#fig3){ref-type="fig"}F). Furthermore, transgene-free *Dgcr8*^Δ/Δ^ iPSCs could be isolated and stably maintained after removal of the STEMCCA lentivirus by Cre adenovirus transduction ([Figure 3](#fig3){ref-type="fig"}G; [Figure S3](#mmc1){ref-type="supplementary-material"}D) ([@bib30]).

Next, we evaluated the differentiation capacity of *Dgcr8*^Δ/Δ^ iPSCs in embryoid bodies (EBs). EBs of *Dgcr8*^Δ/Δ^ iPSCs failed to form cystic cavities over an 11-day period, suggesting a lack of differentiation ([Figures 4](#fig4){ref-type="fig"}A and 4B). The qPCR analyses revealed that pluripotency-associated markers *Oct4* and *Nanog* were maintained but lineage-specific markers, such as *Fgf5* and *Krt18* (ectodermal), *Brachyury* (mesodermal), *Afp* and *Hnf4a* (endodermal), and *Eomes* (extraembryonic), were weakly expressed or absent in EBs of *Dgcr8*^Δ/Δ^ iPSCs. The only gene modestly upregulated in EBs of *Dgcr8*^Δ/Δ^ iPSCs was *Sox1* ([Figure 4](#fig4){ref-type="fig"}C), which is expressed by neural progenitor cells ([@bib39]). To test whether *Dgcr8*^Δ/Δ^ iPSCs could differentiate into more mature neuronal cells, we extended the differentiation protocol under pro-neuronal conditions. Unlike wild-type embryonic stem cells (ESCs), mature Tuj1+ neurons were not differentiated from *Dgcr8*^Δ/Δ^ iPSCs ([Figures 4](#fig4){ref-type="fig"}D and 4E). These data are consistent with the previous finding that *Dgcr8*^−/−^ ESCs poorly produce mature somatic cells ([@bib37]).

Next, we restored DGCR8 expression to levels similar to wild-type ESCs using a human *DGCR8* cDNA ([Figure 5](#fig5){ref-type="fig"}A). The DGCR8-rescued iPSCs exhibited an accelerated cell cycle with a shortened G1 phase compared to *Dgcr8*^Δ/Δ^ iPSCs ([Figure 5](#fig5){ref-type="fig"}B), which underwent slower proliferation, similar to *Dgcr8*^−/−^ ESCs ([@bib38]). To test whether DGCR8 rescue restored the differentiation potential of the *Dgcr8*^Δ/Δ^ iPSCs, we performed a colony-forming assay to examine the number of differentiation-resistant cells within the *Dgcr8*^Δ/Δ^ and DGCR8-rescued iPSCs. Mutant and rescued iPSCs were first induced to differentiation by retinoic acid and then plated back to conditions supporting self-renewal of iPSCs to form colonies. We found that significantly more colonies were formed by *Dgcr8*^Δ/Δ^ iPSCs than by wild-type control ESCs and DGCR8-rescued iPSCs ([Figure 5](#fig5){ref-type="fig"}C). We further evaluated the differentiation potential of rescued iPSCs in a teratoma assay. When injected into immunodeficient mice, the *Dgcr8*^Δ/Δ^ iPSCs formed tumors containing predominantly undifferentiated cells ([Figure 5](#fig5){ref-type="fig"}D). In contrast, the teratoma formed by DGCR8-rescued iPSCs consisted of tissues from all three embryonic layers ([Figures 5](#fig5){ref-type="fig"}E--5E″).

Together, our data support that somatic cells lacking *Dgcr8* and deficient in the biogenesis of canonical miRNAs can be reprogrammed into iPSCs by the Yamanaka factors alone, albeit at decreased reprogramming efficiencies; therefore, canonical miRNA activity facilitates but may be dispensable for iPSC derivation. Consistent with previous reports ([@bib11], [@bib37]), however, miRNAs do appear to be important for subsequent iPSC-derived tissue differentiation.

Discussion {#sec3}
==========

miRNAs may confer robustness to biological systems by integrating into transcriptional regulatory circuitry to reinforce genetic programs and buffer stochastic perturbations ([@bib6], [@bib8]). Mutant mice with deletions of individual miRNA clusters often exhibit only relatively subtle phenotypic defects ([@bib28]). More severe phenotypes are usually observed in mutants with compound deletions of functionally redundant miRNA clusters, suggesting that the subtle defects of individual mutations are at least partially due to functional compensation ([@bib28]). The *Dgcr8* and *Dicer* mutants, which have complete miRNA loss, exhibit the most extreme phenotypic defects. The mutant ESCs can self-renew and express stem cell markers but are functionally defective in spontaneous differentiation ([@bib11], [@bib37]). These results suggest that the regulatory circuitry of pluripotent cells can be sustained solely by transcription factors, while miRNAs are required to initiate and/or sustain the differentiation. Our data support this notion. Because reprogramming is generally considered to be a de-differentiation process, our data suggest that miRNA activity may not be essential for de-differentiation but is essential for normal tissue differentiation.

The mechanisms involved in reprogramming somatic cells to iPSCs by the Yamanaka factors remain poorly understood. Because of the low efficiency and slow kinetics of most reprogramming systems, molecular events that direct somatic cells to pluripotency have been difficult to define. Recent work has demonstrated that miRNAs such as miR-294, miR-302, and miR-181 family members facilitate ([@bib10], [@bib21], [@bib22], [@bib23], [@bib25], [@bib32]), but let-7 family members inhibit, reprogramming ([@bib25], [@bib36]). Therefore, it remains unclear whether miRNA activity as a whole promotes reprogramming and whether miRNAs, in particular those miRNAs shown to promote reprogramming, are necessary for the derivation of iPSCs. Here, we present data demonstrating that while miRNA activity as a whole facilitates reprogramming, the derivation of iPSC may be achieved without canonic miRNAs. Because *Dgcr8*^Δ/Δ^ fibroblasts do not survive extended culture times, they must be transduced with STEMCCA virus for reprogramming 7 or 10 days after Cre expression. Our qPCR analysis detected negligible levels of miRNAs in these cells ([Figure 1](#fig1){ref-type="fig"}B), consistent with a previous report that mature miRNAs are effectively eliminated in *Dicer*^Δ/Δ^ MEFs 6 days after transduction of Cre-expressing lentivirus ([@bib13]). Nevertheless, to exclude the possibility that residual miRNAs may be present and essential for reprogramming, we reprogrammed *Dgcr8*^Δ/Δ^ NSCs, which can be propagated for longer terms to ensure exhaustion of residual miRNAs before transduction of reprogramming factors ([Figure 2](#fig2){ref-type="fig"}A). The prolonged culture of *Dgcr8*^Δ/Δ^ NSCs exhausts residual miRNAs by two mechanisms. First, the *Dgcr8*^Δ/Δ^ NSCs are proliferative; therefore, residual miRNAs are diluted out with each cell division. We split *Dgcr8*^Δ/Δ^ NSCs at a 1:5 ratio for each passage, resulting in the expansion of any single cell to 1.9 × 10^6^--2.4 × 10^8^ (5^9^--5^12^) progeny cells and making it highly unlikely that any residual miRNAs could persist at a biological meaningful concentration by the end of 9--12 passages. Second, the sorted *Dgcr8*^Δ/Δ^ NSCs were reprogrammed after a continuous culture for 45--60 days, which is a sufficient duration to achieve complete degradation of residual miRNAs. Therefore, our data conclusively demonstrate that reprogramming of NSCs may be achieved solely by transcriptional factors without any miRNA activities.

[@bib13] reported that iPSCs could not be isolated from MEFs 6 days after disruption of *Dicer*, which is inconsistent with our data on reprogramming *Dgcr8*^Δ/Δ^ fibroblasts ([Figure 1](#fig1){ref-type="fig"}). DICER is required for the biogenesis of not only canonical miRNAs but also other small RNA species, such as endogenous siRNAs, shRNAs, mirtrons, and short interspersed nuclear element-derived RNAs ([Figure S1](#mmc1){ref-type="supplementary-material"}) ([@bib3]). The discrepancy between the data on reprogramming of *Dicer*-deficient cells and those of *Dgcr8*-deficient cells probably reflects the activities of some DICER-dependent but DGCR8-independent small RNAs. Alternatively, the poorer proliferation capacity of *Dicer*^Δ/Δ^ fibroblasts may contribute to the failure of iPSC derivation ([@bib13]), which is known to be proliferation dependent ([@bib29]). Recently, [@bib41] reported that they were unable to isolate iPSCs from human foreskin fibroblasts that were null for the endogenous miR-302/367 cluster. These data suggested the miR-302/367 cluster is required for human somatic cell reprogramming. Although this result is not consistent with our findings, the discrepancy may be explained by the potential difference in somatic cell reprogramming and/or in the self-renewal of human and mouse pluripotent stem cells ([@bib27]). Alternatively, the discrepancy may be caused by the different miRNA deficiencies of the reprogrammed fibroblasts. In our study, the *Dgcr8*^Δ/Δ^ fibroblasts lacked miRNAs both promoting reprogramming, such as the miR-290s and miR-302s, and inhibiting reprogramming, such as the let-7s; however, the fibroblasts used by [@bib41] were only deficient in the reprogramming-promoting miR-302/367 cluster. The fine balance between pluripotency-promoting and differentiation-inducing miRNAs has been demonstrated to play critical roles in the maintenance of the ground state of pluripotency ([@bib17]), which could be similarly required in reprogramming. Nonetheless, this is an interesting observation that deserves further investigation.

Experimental Procedures {#sec4}
=======================

Mice and the Derivation of ESCs, MEFs, TTFs, and NSCs {#sec4.1}
-----------------------------------------------------

All animal experiments were performed in accordance with guidelines from the University of Alabama at Birmingham (UAB) and NIH. *Dgcr8*^flox/flox^; *LSL-YFP* mice were generated by crossing *Dgcr8*^flox/flox^ mice ([@bib37]) and *R26-LSL-YFP* mice ([@bib31]). ESCs were derived from E3.5 blastocysts as described ([@bib15], [@bib24]). MEFs were isolated from E12.5 embryos, and TTFs were derived from 1-week-old mice. NSCs were isolated from brains of E13.5 embryos following a previously published protocol ([@bib5]).

Cell Culture {#sec4.2}
------------

Mouse ESCs and iPSCs were maintained in mouse ESC maintenance medium (DMEM, 15% fetal bovine serum \[FBS; Gemini Bio\], 0.1 mM non-essential amino acid \[Life Technologies\], β-mercaptoethanol \[Sigma-Aldrich\], and 1,000 U/ml embryonic stem cell growth medium \[ESGRO, Millipore\]) on gelatin-coated plates as described previously ([@bib15]). For EB differentiation, trypsinized wild-type or mutant iPSCs were suspended in Costar ultra-low-attachment cell culture plates (Corning) at a density of 1 × 10^5^ cells/ml in differentiation medium (ESC maintenance medium without ESGRO). EB samples were collected on the indicated days for total RNA extraction. For neuronal differentiation, EBs (day 4) were plated onto tissue culture plates and cultured in N2 medium (DMEM/F12 and N2 supplement \[Gemini Bio\]) for up to 25 days. All fibroblasts were cultured in D10 medium (DMEM and 10% FBS). NSCs were cultured in Mouse Neural Stem Cell Expansion medium (EMD Millipore) on tissue culture plates coated with polyornithine (Sigma-Aldrich) and laminin (EMD Millipore).

Lentiviral Production, iPSC Derivation, and Rescue of Dgcr8 Deficiency {#sec4.3}
----------------------------------------------------------------------

Lentivirus expressing STEMCCA ([@bib30]) were prepared as described ([@bib42]). *Dgcr8*^Δ/Δ^ fibroblasts or NSCs were obtained by Cre adenovirus (Vector Biolabs) transduction of *Dgcr8*^flox/flox^; *LSL-YFP* MEFs or TTFs at an MOI of 500 and FACS sorting of YFP+ cells 48 hr after viral transduction. For fibroblast reprogramming, sorted MEFs or TTFs were continuously cultured for seven or ten days before transduction with STEMCCA lentivirus at an MOI of 2. For NSC reprogramming, sorted NSCs were continuously cultured for 45--60 days before transduction with STEMCCA lentivirus at an MOI of 2. The transduced fibroblasts or NSCs were plated directly onto irradiated MEF feeders in mouse ESC maintenance medium (DMEM, 15% FBS, and 1,000 U/ml ESGRO \[Millipore\]) for up to 4 or 6 weeks, respectively. A human DGCR8 cDNA was subcloned from pFLAG/HA-DGCR8 (Addgene 10921) ([@bib19]) into pSIN-EF2-DEST-Pur, a derivative of pSin-EF2-Oct4-Pur (Addgene 16579) ([@bib40]), to generate the lentiviral vector pSIN-EF2-DGCR8-Pur. *Dgcr8*-deficient iPSCs were transduced with lentivirus expressing DGCR8 and selected for puromycin resistance.

Immunostaining, Immunoblotting, and AP Staining {#sec4.4}
-----------------------------------------------

For immunostaining, iPSCs or EBs were fixed in 4% paraformaldehyde, blocked in Protein Block (Dako), and incubated with the appropriate primary antibodies overnight at 4°C and secondary antibodies for 2 hr at room temperature. Images were acquired by a Nikon Ti-S microscope and processed by Photoshop CS6. For immunoblotting, whole cell extracts were prepared in RIPA buffer (50 mM Tris-HCl \[pH 8.0\], 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS), separated on a 4%--20% SDS-polyacrylamide gel (Bio-Rad), and transferred to polyvinylidene fluoride membrane (Thermo Scientific). Antibodies used were DGCR8 (10996-1-AP, Proteintech), GAPDH (sc-25778, Santa Cruz), SSEA-1 (MC-480, Hybridoma Bank), NANOG (AF2729, R&D Systems), and Tuj1 (801202, BioLegend). For AP staining, cells were fixed in 4% paraformaldehyde and stained using the Leukocyte Alkaline Phosphatase Kit (Sigma-Aldrich).

Genotyping, Karyotyping, and Teratoma Analysis {#sec4.5}
----------------------------------------------

Genotyping was performed as described ([@bib33]). All cell lines were submitted to Cell Line Genetics for G-band karyotyping. Non-obese diabetic severe combined immunodeficiency gamma mice 4--8 weeks of age were injected subcutaneously with 1 × 10^6^--5 × 10^6^ iPSCs. Tumors were harvested, fixed with 10% formalin, and processed by the Comparative Pathology Laboratory at UAB or by HistoWiz.

RNA Extraction and qPCR Analyses {#sec4.6}
--------------------------------

Total RNA was isolated with the DirectZol RNA Kit (Zymo Research), and cDNA were synthesized using the Verso cDNA Synthesis Kit (Thermo Scientific). The qPCR was performed using 2x Absolute Blue qPCR Master Mix (Thermo Scientific) on a ViiA 7 real-time PCR system (Life Technologies). Primers are listed in [Table S2](#mmc1){ref-type="supplementary-material"}. The miRNAs were reverse transcribed using the TaqMan MicroRNA Reverse Transcription Kit (Life Technologies). The qPCR was performed using the TaqMan Universal PCR Master Mix and TaqMan MicroRNA Assays for indicated miRNAs (Life Technologies) on the ViiA 7 system.

Colony-Forming Assay {#sec4.7}
--------------------

The colony-forming assay was performed as previously described ([@bib37]). In brief, undifferentiated wild-type, *Dgcr8*^Δ/Δ^, and rescued *Dgcr8*^Δ/Δ^ iPSCs were cultured in differentiation medium supplemented with 2 μM retinoic acid (Sigma-Aldrich) for the indicated days, trypsinized to single cells, replated at a density of 100 cells/cm^2^ onto gelatin-coated plates, and cultured in ESC maintenance medium for 7 days before AP staining. Experiments were repeated three times, and only AP-positive colonies were scored.

Cell-Cycle Analysis {#sec4.8}
-------------------

Cell-cycle analysis was performed as described ([@bib42]). In brief, cells at 30%--50% confluency were trypsinized and fixed in cold 70% ethanol at −20°C overnight. Cells were washed twice in PBS, treated with 10 μg/ml DNase-free RNase A at 37°C for 30 min, and resuspended at a density of 5 × 10^5^ cells/ml in PBS with 5 μg/ml propidium iodide. Cells were analyzed on a Becton Dickinson Fortessa flow cytometer, and data were analyzed by the FlowJo VX software.

Supplemental Information {#app2}
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![Reprogramming of *Dgcr8*^Δ/Δ^ MEFs and TTFs\
(A) Schematic of the reprogramming strategy. R26-loxP-STOP-loxP-YFP, ROSA26-driven loxP-flanked STOP sequence followed by an YFP reporter; Ad-Cre, Cre-expressing adenovirus; OSKM, reprogramming factors OCT4, SOX2, KLF4, and c-MYC.\
(B) QPCR analyses of mature miRNAs in *Dgcr8*^flox/flox^ and *Dgcr8*^Δ/Δ^ TTFs 7 or 10 days after Cre expression. Shown are tested miRNAs reliably expressed in *Dgcr8*^flox/flox^ TTFs. Expression of mature miRNA was normalized to small nucleolar RNA 142. n = 3 independent biological repeats. Error bar, SD.\
(C) Representative flow cytometry analysis of the *Dgcr8*^Δ/Δ^;*LoxP-STOP-LoxP-YFP* fibroblasts 48 hr after mock (left) or Cre adenovirus (right) transduction. PI, propidium iodide.\
(D) Merged bright field and YFP image of fibroblast-derived *Dgcr8*^Δ/Δ^ iPSCs. Scale bars, 100 μm.\
(E) Reprogramming efficiency of *Dgcr8*^flox/flox^ and *Dgcr8*^Δ/Δ^ fibroblasts. n = 4 or 5 independent biological repeats. Error bar, SD. See also [Table S1](#mmc1){ref-type="supplementary-material"}.\
(F) PCR genotyping of wild-type, *Dgcr8*^flox/flox^ TTFs, and *Dgcr8*^Δ/Δ^ TTF-derived iPSC clones derived from a representative reprogramming experiment. Although most iPSC clones have *Dgcr8* disrupted completely, approximately 15% of YFP+ clones, such as iPSC-5, retain one functional *Dgcr8* allele. Diamond, *Dgcr8*^+^; arrow, *Dgcr8*^flox^; arrowhead, *Dgcr8*^Δ^.](gr1){#fig1}

![Reprogramming of *Dgcr8*^Δ/Δ^ NSCs\
(A) Schematic of the reprogramming strategy. R26-loxP-STOP-loxP-YFP, ROSA26-driven loxP-flanked STOP sequence followed by an YFP reporter; Ad-Cre, Cre-expressing adenovirus; OSKM, reprogramming factors OCT4, SOX2, KLF4, and c-MYC.\
(B) Bright field image of *Dgcr8*^Δ/Δ^ NSCs continuously cultured for 60 days. Scale bars, 100 μm.\
(C) PCR genotyping of wild-type MEFs, *Dgcr8*^flox/flox^ NSCs, *Dgcr8*^Δ/Δ^ NSCs, and representative *Dgcr8*^Δ/Δ^ NSC-derived iPSC clones. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.\
(D) QPCR analyses of mature miRNAs in *Dgcr8*^flox/flox^ and *Dgcr8*^Δ/Δ^ NSCs. Expression of mature miRNA was normalized to small nucleolar RNA 142. n = 3 independent biological repeats. Error bar, SD.\
(E) Merged bright field and YFP image of NSC-derived *Dgcr8*^Δ/Δ^ iPSCs. Scale bars, 100 μm.\
(F) Reprogramming efficiency of *Dgcr8*^flox/flox^ and *Dgcr8*^Δ/Δ^ NSCs. n = 3 independent biological repeats. Error bar, SD.](gr2){#fig2}

![Characterization of *Dgcr8*^Δ/Δ^ iPSCs\
(A--C′) *Dgcr8*^Δ/Δ^ iPSCs expressed pluripotency-associated markers. (A) AP, (B) SSEA-1 (red) and DAPI (blue), (C) NANOG, and (C′) DAPI. Scale bars, 100 μm (white) and 50 μm (green). See also [Figure S3](#mmc1){ref-type="supplementary-material"}A for characterization of NSC-derived *Dgcr8*^Δ/Δ^ iPSCs.\
(D) QPCR analyses of *Dgcr8* in wild-type ESCs, *Dgcr8*^Δ/Δ^ ESCs, and *Dgcr8*^Δ/Δ^ iPSC clones derived from MEFs or TTFs. Data were normalized to the mRNA levels of β-actin gene *Actb*. n = 3 independent biological repeats. Error bar, SD.\
(E) A normal karyotype (40, XY) of *Dgcr8*^Δ/Δ^ iPSCs. See also [Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C.\
(F) QPCR analyses of *Oct4* (left) and *Sox2* (right) in representative *Dgcr8*^Δ/Δ^ iPSC clones derived from MEFs or TTFs. Endo, endogenous expression; tg, transgene expression. Data were normalized to the mRNA levels of β-actin gene *Actb*. n = 3 independent biological repeats. Error bar, SD.\
(G) PCR confirmation of transgene-free *Dgcr8*^Δ/Δ^ iPSC clones. The STEMCCA lentivirus in representative *Dgcr8*^Δ/Δ^ iPSC clones was removed by Cre adenovirus transduction. See also [Figure S3](#mmc1){ref-type="supplementary-material"}D for characterization of the transgene-free *Dgcr8*^Δ/Δ^ iPSCs.](gr3){#fig3}

![*Dgcr8*^Δ/Δ^ iPSCs Are Deficient in Differentiation\
(A and B) EBs formed by (A) wild-type ESCs and (B) *Dgcr8*^Δ/Δ^ iPSCs. The arrow points to a cystic cavity of an EB. Scale bar, 200 μm.\
(C) QPCR analyses of EBs formed by wild-type ESCs and *Dgcr8*^Δ/Δ^ iPSCs. The analyzed markers include *Oct4* and *Nanog* (pluripotency associated); *Sox1*, *Fgf5*, and *Krt18* (ectodermal); *Brachyury* (mesodermal); *Afp* and *Hnf4a* (endodermal); and *Eomes* (trophectodermal). Samples were collected at indicated days of differentiation. Data were normalized to the mRNA levels of β-actin gene *Actb*. n = 3 independent biological repeats. Error bar, SD.\
(D and E) Immunostaining of Tuj1, a marker specifically expressed by neurons, in EBs of (D) wild-type and (E) *Dgcr8*^Δ/Δ^ iPSCs. Scale bar, 100 μm.](gr4){#fig4}

![Rescue of DGCR8 Restored Differentiation Potential of *Dgcr8*^Δ/Δ^ iPSCs\
(A) Immunoblot of DGCR8 (top) and GAPDH (bottom) in wild-type ESC, *Dgcr8*^Δ/Δ^ TTF-iPSC, and DGCR8-rescued *Dgcr8*^Δ/Δ^ TTF-iPSC extracts.\
(B) Cell-cycle analyses of *Dgcr8*^Δ/Δ^ iPSCs and rescued *Dgcr8*^Δ/Δ^ iPSCs. n = 3 independent biological repeats.\
(C) Colony-forming assay of wild-type, *Dgcr8*^Δ/Δ^, and DGCR8-rescued *Dgcr8*^Δ/Δ^ iPSCs. Cells were first induced to differentiate by treatment with retinoic acid for the indicated days and then returned to conditions permissive to self-renewal for 7 days. Colonies positive for AP were scored. n = 3 independent biological repeats. Error bar, SD. ^∗^p \< 0.05; ^∗∗^p \< 0.01; Student's t test between *Dgcr8*^Δ/Δ^ and rescued iPSCs.\
(D--E″) Teratoma analyses. Shown are teratomas generated by (D) *Dgcr8*^Δ/Δ^ iPSCs, which contain virtually no differentiated somatic tissues and (E--E″) the DGCR8-rescued *Dgcr8*^Δ/Δ^ iPSCs, which contain tissues from all three embryonic germ layers: (E) neural epithelium, (E′) cartilage and muscle, and (E″) respiratory epithelium. Scale bar, 100 μm.](gr5){#fig5}
